Sign In
Buy PRCT
$16.69
-0.86 (-4.90%)
At Close: Jul 24, 2026
PROCEPT BioRobotics Received U.S. FDA Approval to Initiate Pivotal Randomized Clinical Study for Prostate Cancer
04:04pm, Monday, 07'th Oct 2024
A Prospective, Randomized, Multicenter Study Assessing the Safety and Efficacy of Aquablation Therapy in Men with Grade Group 1 to 3 Localized Prostate Cancer
PROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024
04:03pm, Wednesday, 28'th Aug 2024
SAN JOSE, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative
Procept BioRobotics: Risk Capital Unlock With FDA Hydros Approval
08:30am, Tuesday, 27'th Aug 2024
The FDA's approval of Procept's Hrydos system is a meaningful catalyst to the investment debate. Investors have added ~$5/share in market value since the announcement. PRCT's Q2 '24 numbers were equal
PROCEPT BioRobotics' (PRCT) HYDROS System Gets FDA Clearance
02:06pm, Thursday, 22'nd Aug 2024
PROCEPT BioRobotics (PRCT) announces the FDA 510(k) clearance of its HYDROS Robotic System for providing better BPH treatment.
PROCEPT (PRCT) Grows in Urology With FDA Clearance for HYDROS
10:16am, Thursday, 22'nd Aug 2024
PROCEPT's (PRCT) HYDROS Robotic System leverages AI-driven technology, specifically FirstAssist AI, to optimize treatment planning.
PROCEPT BioRobotics Announces FDA Clearance of the HYDROS™ Robotic System, the Next-Generation, AI-Powered Platform for Aquablation® Therapy
07:00am, Wednesday, 21'st Aug 2024
Designed to improve efficiency, enhance surgeon and staff experience and deliver a more accurate and consistent treatment plan for better clinical outcomes Designed to improve efficiency, enhance surg
3 Robotics Stocks to Sell in August Before They Crash & Burn
04:30pm, Wednesday, 14'th Aug 2024
While the global industrial automation market is poised for a CAGR of 8.3% between 2024 and 2031, according to SkyQuest, it bears winnowing out the particulars of the market, including identifying rob
Is PROCEPT BioRobotics the Next Big Thing in Surgical Robotics?
07:15am, Wednesday, 14'th Aug 2024
Surgical robotics company PROCEPT BioRobotics Co. NASDAQ: PRCT developed the AquaBeam Robotic System for the treatment of benign prostatic hyperplasia (BPH) among aging men. The company went public du
PROCEPT BioRobotics Corporation (PRCT) Q2 2024 Earnings Call Transcript
09:23pm, Saturday, 03'rd Aug 2024
PROCEPT BioRobotics Corporation (NASDAQ:PRCT ) Q2 2024 Earnings Conference Call August 1, 2024 4:30 AM ET Company Participants Matt Bacso - Vice President, Investor Relations Reza Zadno - President &
PROCEPT BioRobotics Corporation (PRCT) Reports Q2 Loss, Tops Revenue Estimates
06:51pm, Thursday, 01'st Aug 2024
PROCEPT BioRobotics Corporation (PRCT) came out with a quarterly loss of $0.50 per share versus the Zacks Consensus Estimate of a loss of $0.52. This compares to loss of $0.56 per share a year ago.
PROCEPT BioRobotics® Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue and EBITDA Guidance
04:03pm, Thursday, 01'st Aug 2024
SAN JOSE, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing tran
PROCEPT BioRobotics to Report Second Quarter 2024 Financial Results on August 1, 2024
04:03pm, Monday, 15'th Jul 2024
SAN JOSE, Calif., July 15, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing tr
You've Been Warned! 3 Robotics Stocks to Buy Now or Regret Forever.
04:38pm, Thursday, 27'th Jun 2024
Right now, growth investors are focused primarily on opportunities in the semiconductors and artificial intelligence stocks space. That's understandable, given how fast technology is advancing in thos
PROCEPT BioRobotics Announces New CPT® Category I Code from the American Medical Association for Aquablation therapy
04:03pm, Monday, 17'th Jun 2024
SAN JOSE, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing tr
PROCEPT BioRobotics to Present at Upcoming 2024 Truist Securities MedTech Conference on June 18, 2024
04:03pm, Monday, 03'rd Jun 2024
SAN JOSE, Calif., June 03, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative
